3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide

C23H20N6O7S — CID 154008052

IUPAC3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide
SMILESCC(O)=C(/N=N/c1cccc(C(=O)Nc2cccc(S(N)(=O)=O)c2)c1)C(=O)Nc1cccc([N+](=O)[O-])c1
InChIInChI=1S/C23H20N6O7S/c1-14(30)21(23(32)26-16-6-3-9-19(12-16)29(33)34)28-27-18-8-2-5-15(11-18)22(31)25-17-7-4-10-20(13-17)37(24,35)36/h2-13,30H,1H3,(H,25,31)(H,26,32)(H2,24,35,36)/b21-14?,28-27+
InChIKeyBXHIYFOEHYZOBA-CWZOPYKCSA-N
MW524.52 g/mol
LogP4.01
Rot. Bonds8

About 3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide

3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide (PubChem CID 154008052) has the molecular formula C23H20N6O7S and a molecular weight of 524.52 g/mol. Its IUPAC name is 3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide.

Molecular Properties

Compound Name3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide
PubChem CID154008052
Molecular FormulaC23H20N6O7S
Molecular Weight524.52 g/mol
Exact Mass524.11
IUPAC Name3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide
SMILESCC(O)=C(/N=N/c1cccc(C(=O)Nc2cccc(S(N)(=O)=O)c2)c1)C(=O)Nc1cccc([N+](=O)[O-])c1
InChIInChI=1S/C23H20N6O7S/c1-14(30)21(23(32)26-16-6-3-9-19(12-16)29(33)34)28-27-18-8-2-5-15(11-18)22(31)25-17-7-4-10-20(13-17)37(24,35)36/h2-13,30H,1H3,(H,25,31)(H,26,32)(H2,24,35,36)/b21-14?,28-27+
InChIKeyBXHIYFOEHYZOBA-CWZOPYKCSA-N
XLogP4.01
TPSA206.45 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500524.52
LogP ≤ 54.01
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}

Analyze 3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide?
The IUPAC name of 3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide (CID 154008052) is 3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide.
What is the SMILES notation for 3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide?
The canonical SMILES for 3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide is CC(O)=C(/N=N/c1cccc(C(=O)Nc2cccc(S(N)(=O)=O)c2)c1)C(=O)Nc1cccc([N+](=O)[O-])c1.
What is the InChIKey of 3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide?
The InChIKey is BXHIYFOEHYZOBA-CWZOPYKCSA-N. The full InChI is InChI=1S/C23H20N6O7S/c1-14(30)21(23(32)26-16-6-3-9-19(12-16)29(33)34)28-27-18-8-2-5-15(11-18)22(31)25-17-7-4-10-20(13-17)37(24,35)36/h2-13,30H,1H3,(H,25,31)(H,26,32)(H2,24,35,36)/b21-14?,28-27+.
What are the key properties of 3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide?
3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide has a molecular weight of 524.52 g/mol, XLogP of 4.01, 8 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[[3-hydroxy-1-(3-nitroanilino)-1-oxobut-2-en-2-yl]diazenyl]-N-(3-sulfamoylphenyl)benzamide is sourced from PubChem (CID 154008052), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).